课题基金 / 基金详情

项目摘要

项目成果

CHANDRA MOHAN的其他基金

相似基金

相关文献

中文摘要
翻译
狼疮是一种系统性自身免疫性疾病,其遗传学和免疫学起源复杂。肾 疾病是狼疮发病率和死亡率的主要原因,特别是在少数民族妇女中。 虽然连续肾活检可能是密切监测狼疮性肾炎进展的理想方法,但它可能 不实际或者不可行。因此,这些研究的长期目标是确定潜在的生物标志物, 可用于监测狼疮性肾病的进展。 使用不同的蛋白质组学方法,我们已经发现了几种分子,出现在尿液中, 抗体介导的肾炎。我们完成的横断面研究帮助揭示了6种潜在的 小鼠和狼疮患者尿液中的生物标志物候选物。在本建议中,我们将研究一组 狼疮患者,其中90%是少数民族,以纵向方式,以确定是否有任何 的尿生物标志物候选者可能更好地预测耀斑,严重的组织学肾炎,或结束 阶段性肾病,与目前使用的实验室标准相比。此外,我们建议设立 这些生物标志物对狼疮性肾炎以及蛋白尿和肾炎的其他原因的特异性。 由于狼疮终末期肾病的发生率很高,因此早期诊断和及时治疗是非常重要的。 绝对必要在这些患者的尿液中鉴定出更具预测性的生物标志物可能会对他们的健康产生影响。 狼疮性肾炎的临床表现有哪些?
英文摘要
Lupus is a systemic autoimmune disease that is complex in genetics and its immunological origins. Renal disease is a leading cause of morbidity and mortality in lupus, particularly among minority women. Although serial renal biopsies may be ideal in closely monitoring the progression of lupus nephritis, it may not be practical or feasible. Hence, the long-term goal of these studies is to identify potential biomarkers that may be of use in monitoring the progression of renal disease in lupus. Using different proteomic approaches, we have uncovered several molecules that appear in the urine during antibody-mediated nephritis. Our completed cross-sectional studies have helped uncover 6 potential biomarker candidates in the urine of mice and patients with lupus. In this proposal, we will study a cohort of lupus patients, 90% of whom are minority individuals, in a longitudinal fashion in order to determine if any of the urinary biomarker candidates might be better at predicting flares, severe histological nephritis, or end stage renal disease, compared to currently used laboratory yardsticks. In addition, we propose to establish the specificity of these biomarkers for lupus nephritis, as well as other causes of proteinuria and nephritis. Given the high incidence of end stage renal disease in lupus, early diagnosis and prompt treatment is absolutely essential. Identification of more predictive biomarkers in the urine of these patients could have a profound impact on the clinical management of lupus nephritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnostic utility of antibodies to post-translationally modified nucleosomes in lupus nephritis
  • 批准号:
    10683684
  • 项目类别:
  • 资助金额:
    $15.83万
  • 财政年份:
    2023
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
Objective Classification of Lupus Nephritis
  • 批准号:
    10683624
  • 项目类别:
  • 资助金额:
    $66.94万
  • 财政年份:
    2023
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
Lupus Nephritis Neural Network, LuNN
  • 批准号:
    10246669
  • 项目类别:
  • 资助金额:
    $10.08万
  • 财政年份:
    2020
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
Monitoring Disease in Lupus
  • 批准号:
    10583454
  • 项目类别:
  • 资助金额:
    $54.2万
  • 财政年份:
    2019
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
海外基金